妊娠期高血压应用酚妥拉明联合硫酸镁治疗的价值评析.docVIP

精品论文 参考文献 妊娠期高血压应用酚妥拉明联合硫酸镁治疗的价值评析 湖南省湘西自治州人民医院 湖南吉首 416000 【摘 要】目的：研究妊娠期高血压应用酚妥拉明联合硫酸镁治疗的价值。方法：纳入的对象来自我院2013年3月-2015年11月83例妊娠期高血压患者。将所有纳入的患者随机分为L组和L+F组。L组仅采取硫酸镁进行治疗；L+F组在L组方案上增加酚妥拉明治疗。比较（1）降压总有效率；（2）剖宫产率、产妇和新生儿不良事件发生率；（3）干预前和干预后患者产妇舒张压、收缩压的差异。结果：（1）L+F组对比L组降压总有效率更高，P＜0.05；（2）L+F组对比L组剖宫产率、产妇和新生儿不良事件发生率更低，P＜0.05；（3）干预前两组产妇舒张压、收缩压相似，P＞0.05；干预后L+F组对比L组产妇舒张压、收缩压改善更显著，P＜0.05。结论：妊娠期高血压应用酚妥拉明联合硫酸镁治疗的价值高，可有效降压，减少剖宫产率，改善母婴结局，值得推广。 【关键词】妊娠期高血压；酚妥拉明；硫酸镁；治疗价值 【 abstract 】 objective：to study the gestational hypertension using phentolamine combined the value of magnesium sulfate treatment.Methods：into the object from the hospital in March 2013 - in November 2015，83 cases of patients with gestational hypertension.Incorporate all the patients were randomly divided into L groups and L + F group.L group only take magnesium sulfate treatment；L + F group in L increase phentolamine treatment plan.（1）the step-down total effective rate；（2）the cesarean delivery rate，incidence of maternal and neonatal adverse events；（3）the intervention before and after intervention in patients with maternal diastolic and systolic blood pressure difference.Results：（1）the L + F group contrast L step-down total effective rate is higher，P lt; 0.05；（2）L + F group contrast L cesarean delivery rate，maternal and neonatal lower incidence of adverse events，P lt; 0.05；（3）the intervention before maternal diastolic and systolic blood pressure is similar in both groups，P gt; 0.05；After the intervention of L + F group contrast L maternal diastolic and systolic blood pressure improved more significantly，P lt; 0.05.Conclusion：the gestational hypertension phentolamine combined magnesium sulfate treatment value is high，can effective step-down，reduce cesarean section rate，improve and outcomes，is worth promoting. 【 key words 】 gestational hypertension；Phentolamine.Magnesium sulfate；Therapeutic value 妊娠期高血压为常见妇产科疾病，多在妊娠20周内发生，对母婴健康造成严重威胁，可导致产后出血和胎儿窘迫等，甚至导致母婴死亡，需及时采用降压药物、解痉药物等进行治疗。本研究对妊娠期高血压应用酚妥拉明联合硫酸镁治疗的价值进行分析，报告